U.S. markets open in 9 hours 9 minutes
  • S&P Futures

    4,371.00
    +22.75 (+0.52%)
     
  • Dow Futures

    34,059.00
    +220.00 (+0.65%)
     
  • Nasdaq Futures

    15,078.25
    +68.75 (+0.46%)
     
  • Russell 2000 Futures

    2,192.20
    +15.40 (+0.71%)
     
  • Crude Oil

    70.98
    +0.69 (+0.98%)
     
  • Gold

    1,762.30
    -1.50 (-0.09%)
     
  • Silver

    22.25
    +0.05 (+0.23%)
     
  • EUR/USD

    1.1737
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    1.3090
    -0.0610 (-4.45%)
     
  • Vix

    25.71
    +4.90 (+23.55%)
     
  • GBP/USD

    1.3674
    +0.0015 (+0.11%)
     
  • USD/JPY

    109.6040
    +0.1840 (+0.17%)
     
  • BTC-USD

    42,608.48
    -2,901.99 (-6.38%)
     
  • CMC Crypto 200

    1,065.06
    -69.32 (-6.11%)
     
  • FTSE 100

    6,903.91
    -59.73 (-0.86%)
     
  • Nikkei 225

    29,924.59
    -575.46 (-1.89%)
     

NeuroMetrix stock more than triples on massive volume after fibromyalgia treatment gets FDA boost

·1 min read
NeuroMetrix stock more than triples on massive volume after fibromyalgia treatment gets FDA boost
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of NeuroMetrix Inc. rocketed 241% toward a two-year high on record volume, after the Massachusetts-based medical device company said its Quell transcutaneous electric nerve stimulator received "Breakthrough Designation" from the Food and Drug Administration to treat fibromyalgia symptoms in adults. Trading volume ballooned to 228.3 million shares, compared with the full-day average over the past 30 days of about 125,600 shares, to make the stock the biggest gainer and most actively traded